Related content

Progress Towards Therapeutic Small Molecule MEK Inhibitors for Use in Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 215-229

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging MEK inhibitors

By McCubrey James A   Steelman Linda S   Abrams Steven L   Chappell William H   Russo Suzanne   Ove Roger   Milella Michele   Tafuri Agostino   Lunghi Paolo   Bonati Antonio   Stivala Franca   Nicoletti Ferdinando   Libra Massimo   Martelli Alberto M   Montalto Giuseppe   Cervello Melchiorre  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 203-223

Informa Healthcare

Access to resources Recommend Favorite

Extracellular Signal-Regulated Kinases Modulate DNA Damage Response - A Contributing Factor to Using MEK Inhibitors in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 18, Iss. 35, 2011-12 ,pp. : 5476-5482

Bentham Science Publishers

Access to resources Recommend Favorite

RAS/RAF/MEK Inhibitors in Oncology

By  

Current Medicinal Chemistry, Vol. 19, Iss. 8, 2012-03 ,pp. : 1164-1176

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects

By Fingleton Barbara  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 3, 2003-06 ,pp. : 385-397

Informa Healthcare

Access to resources Recommend Favorite